Skip to content
2000
Volume 13, Issue 8
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

A series of 2-((5-aryloxy-1-methyl-3-methyl-1H-pyrazol-4-yl)methylene) hydrazinecarboxamides (6a-6l) and 2-((5-aryloxy-1-methyl-3-phenyl-1H-pyrazol-4-yl)methylene) hydrazinecarboxamides (7a-7l) were designed and synthesized. The maximal electroshock shock (MES) and subcutaneous pentylenetetrazole (sc-PTZ) seizure models in mice were used to evaluate the antiepileptic effect of compounds synthesized. Further, the acute neurotoxicity profile was also studied via the rotarod test. The results of sc-PTZ test indicate that a majority of compounds possessed anticonvulsant activity with long duration of protection effects. Among of them, compound 6k was found to be the most promising one, with an ED50 value of 20.4 mg/kg (in sc-PTZ model) and a PI value of 10.8, possessing higher anti-PTZ activity and wider safety margin than valproate and ethosuximide.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180813666160711155752
2016-10-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180813666160711155752
Loading

  • Article Type:
    Research Article
Keyword(s): Anticonvulsant; maximal electroshock; pentylenetetrazole; pyrazole; semicarbazone
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test